Researchers engineered a dimeric radioligand targeting fibroblast activation protein that demonstrated superior tumor accumulation and extended retention over a clinical ...
Radiometal-labelled olaparib derivatives fail to cross cell membranes, rendering them unsuitable for targeted radionuclide therapy or PET imaging of intranuclear ...
Researchers established an integrated reactor production workflow using thin-layer gadolinium-160 chloride targets and direct hydrochloric acid extraction chromatography to generate ...
A new review consolidates the synthetic strategies used to convert macrocyclic chelators such as DOTA and NOTA into bifunctional agents ...
A scientific review details the clinical momentum, biological complexity, and dosimetric challenges shaping the next era of precision radiopharmaceutical cancer ...
A new review maps how target-specific radiopharmaceuticals pair matched diagnostic and therapeutic radionuclides to deliver precision cancer therapy from imaging ...
Researchers report a scalable two-stage chromatographic process that yields high-purity, no-carrier-added terbium-161 from enriched gadolinium-160 targets with quality specifications suitable ...
The RTOG Foundation, a renowned non-profit entity specializing in cancer clinical trials, has recently initiated a groundbreaking study known as ...
A groundbreaking advance in the treatment of solitary fibrous tumors (SFT), a rare and often challenging malignancy, has emerged from ...
